Guru Ownership Over Time
Guru Analysis for Recursion Pharmaceuticals, Inc. (RXRX)
Recursion Pharmaceuticals, Inc. (RXRX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2025, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $155.32 M.
Top institutional holders include Catherine Wood.
Institutional sentiment is currently Bullish. This is evidenced by a $19.16 M net inflow during the quarter.
Recent activity highlights Catherine Wood who increased their stake by 1.7%.
| Portfolio Manager | % of portfolio | Activity | Shares | Value | Peroid |
|---|---|---|---|---|---|
| 0.97% | Add 1.7% | 33,545,499 | $163.7 M | Q3 2025 |
| Period | Portfolio Manager | Activity | Share change | % change to portfolio |
|---|
| Period | Portfolio Manager | Activity | Share change | % change to portfolio |
|---|
| Period | Portfolio Manager | Activity | Share change | % change to portfolio |
|---|
| Portfolio Manager | Option Type | % of portfolio | Activity | Shares | Value | Period |
|---|
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown(Q3 2025)
Guru Consensus (Q3 2025)
FAQs for Recursion Pharmaceuticals, Inc. (RXRX)
Top Guru holders include Catherine Wood ($163.7 M). Collectively, tracked Gurus hold 33.55 M shares.
Based on recent 13F filings, the sentiment is **Positive (Net Buy)**. There was a net inflow of $19.16 M, with 2 Gurus buying and 0 Gurus selling.
No tracked Gurus reduced or sold out of their positions in RXRX during the most recent reported quarter.
Yes, 0 Gurus opened new positions in RXRX, and 2 added to their existing holdings. Total buy value was $19.16 M.